BLOG A TransPerfect World

 
Life SciencesBLOG 
07.22.20
Remote Investigator Meetings: Another Piece of the Virtual Trial Puzzle
07.16.20
4 Ways to Avoid COA Source Revisions and Mitigate Risk in Your Global Clinical Trials
07.16.20
Establishing a Culture of Inspection Readiness
07.14.20
Navigating the CMS Requirements for Medicare Advantage Plans in the Wake of COVID-19
06.25.20
Swimming in a Data Lake of eCOA Wearables
06.01.20
Prospective Writing to Prepare Disclosure-Ready Clinical Trial Documentation
05.27.20
Globalization of Clinical Trial Registration in Light of COVID-19
05.20.20
5 Key Considerations When Moving to Remote Monitoring in Your Ongoing Clinical Trials
05.06.20
Best Practice for Using Technology and AI to Manage the End-to-End Medical Information Content Lifecycle
04.07.20
A Summary of FDA Guidance on COVID-19: Patient Safety and Adapting Processes
04.06.20
Clinical Delivery within COVID-19: We Have the Ability to Adapt
03.19.20
Plain-Language Abstracts: A Benefit to Your Research
 

Select Your Language


The Americas Europe Africa & Middle East Asia Pacific